Filing Flows › Rockwell Medical (RMTI) › Q4 2025
Rockwell Medical (RMTI) Q4 2025 earnings results (fourth quarter 2025)
10-K filed Mar 26, 2026
Rockwell Medical (RMTI) reported revenue of $18.3M for the fourth quarter 2025 (Q4 2025), -26% from a year earlier and +15% from the quarter before. Operating margin was -2.2%, net loss $554K (3.0% of revenue).
Rockwell Medical, Q4 2025: revenue $18.3M (-26% year over year), operating margin -2.2%, net loss $554K, operating cash flow $2.3M. The chart follows the revenue to costs, profit and cash.
| Q4 2025 | Amount | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $18.3M | +15% | -26% |
| Operating profit | −$398K | — | — |
| Net earnings | −$554K | — | — |
| Operating cash flow | $2.3M | — | +165% |
| Free cash flow | $2.2M | — | +369% |
What changed
Revenue was $18.3M in Q4 2025, down 26% year over year and up 15% from the previous quarter.
Gross margin was 21.1%, up 6.4 points from Q4 2024. Operating costs exceeded revenue by $398K, an operating margin of -2.2%. Operating expenses grew 3% against a revenue fall of 26%. The fastest-growing cost line was General & admin (+13%). The quarter ended with a net loss of $554K, narrower than the previous quarter's $1.8M loss.
Operating cash flow was $2.3M (up 165% year over year). Non-cash charges added back $546K of depreciation and amortization and $457K of share-based compensation. Working capital and other items added $1.8M. Capital expenditures of $86K left free cash flow of $2.2M.
Questions
What was Rockwell Medical's revenue in the fourth quarter 2025?
Rockwell Medical (RMTI) reported revenue of $18.3M for the fourth quarter 2025 (Q4 2025), -26% from a year earlier and +15% from the quarter before.
Was Rockwell Medical profitable in the fourth quarter 2025?
Operating loss was $398K (-2.2% of revenue) and net loss $554K.
Source: Rockwell Medical 10-K on SEC EDGAR.